Factors related to alexithymia in patients with systemic sclerosis: a tight relationship with facial image dissatisfaction.
Alexithymia
Anxiety
Depression
Pain
QoL
Systemic sclerosis
Journal
Rheumatology international
ISSN: 1437-160X
Titre abrégé: Rheumatol Int
Pays: Germany
ID NLM: 8206885
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
25
10
2018
accepted:
26
11
2018
pubmed:
1
12
2018
medline:
3
1
2020
entrez:
1
12
2018
Statut:
ppublish
Résumé
To assess clinical and psychosocial factors related to alexithymia in systemic sclerosis (SSc). We enrolled 40 consecutive SSc patients in a cross-sectional study evaluating alexithymia with Toronto Alexithymia scale (TAS-20). We measured Beck Depression inventory (BDI), Hamilton Anxiety rating scale (HAM-H), 36-Items Short-Form Healthy Survey (SF-36), Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue, Visual Analog Scale (VAS) pain, Pittsburgh Sleep Quality Index (PSQI), Satisfaction with Appearance Scale (SWAP), and Mouth Handicap in Systemic Sclerosis (MHISS). The prevalence of alexithymia was 42%. Alexithymic patients presented increased depressive (p = ≤ 0.001) and anxiety symptoms (p = ≤ 0.001), sleep disorders (p = 0.03), pain (p = 0.02), esthetic concerns (p = 0.03), disability in activities (p = 0.03) and reduced scores of SF-36 in mental components summary (MCS) (p = ≤ 0.001) and physical components summary (PCS) (p = 0.01). We found significant correlations with sleep disorders (r = 0.41, p = ≤ 0.001), BID (r = 0.35, p = 0.04), facial image dissatisfaction (r = 0.35, p = 0.04), mouth disability (r = 0.51, p = 0.005), depressive (r = 0.6, p = ≤ 0.001), and anxiety symptoms (r = 0.48, p = ≤ 0.001), fatigue (r = - 0.45 p = 0.005), SF-36 PCS (r = - 0.51, p = ≤ 0.001) and MCS (r = - 0.65, p = ≤ 0.001). In multiple linear regression analysis, SWAP facial was the only variable associated with TAS-20 [0.99 (0.48) p = 0.05]. Alexithymia correlates with several psychosocial factors but seems strongly related to facial image dissatisfaction.
Identifiants
pubmed: 30498976
doi: 10.1007/s00296-018-4214-y
pii: 10.1007/s00296-018-4214-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
461-467Références
J Psychosom Res. 2001 May;50(5):255-61
pubmed: 11399282
J Affect Disord. 2002 Feb;68(1):41-7
pubmed: 11869781
Ann Rheum Dis. 2003 Sep;62(9):901-3
pubmed: 12922968
Health Qual Life Outcomes. 2003 Dec 16;1:79
pubmed: 14678568
Arthritis Rheum. 2005 Apr 15;53(2):256-62
pubmed: 15818719
Semin Arthritis Rheum. 2007 Oct;37(2):93-8
pubmed: 17363039
Arthritis Rheum. 2007 Aug 15;57(6):1089-97
pubmed: 17665491
Clin Rheumatol. 2008 Jun;27(6):743-9
pubmed: 18040599
Arthritis Care Res (Hoboken). 2010 Dec;62(12):1779-86
pubmed: 20665750
Compr Psychiatry. 2011 Nov-Dec;52(6):754-62
pubmed: 21193176
Psychol Health Med. 2011 May;16(3):304-12
pubmed: 21491338
Rheumatol Int. 2012 Sep;32(9):2785-90
pubmed: 21847653
PLoS One. 2012;7(3):e33281
pubmed: 22457749
Neurol Sci. 2013 Apr;34(4):511-9
pubmed: 22526760
Biomed Res Int. 2013;2013:507493
pubmed: 23984376
Ann Rheum Dis. 2013 Nov;72(11):1747-55
pubmed: 24092682
Arthritis Care Res (Hoboken). 2014 May;66(5):679-86
pubmed: 24127403
Clin Rheumatol. 2014;33(10):1443-50
pubmed: 24718486
Tijdschr Psychiatr. 2014;56(12):798-806
pubmed: 25510454
Psychiatry Res. 2015 May 30;227(1):1-9
pubmed: 25769520
Rheum Dis Clin North Am. 2015 Aug;41(3):519-28
pubmed: 26210133
Eur J Neurol. 2016 Apr;23(4):744-50
pubmed: 26782789
Allergy. 2017 Jul;72(7):1054-1060
pubmed: 27886387
J Clin Rheumatol. 2017 Mar;23(2):80-86
pubmed: 28099215
Scand J Psychol. 2018 Apr;59(2):167-176
pubmed: 29110306
Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):150-160
pubmed: 29303706
Psychiatr Clin North Am. 1988 Sep;11(3):351-66
pubmed: 3067228
J Psychosom Res. 1994 Jan;38(1):33-40
pubmed: 8126688
J Psychosom Res. 1996 Dec;41(6):551-9
pubmed: 9032718
J Clin Epidemiol. 1998 Nov;51(11):1025-36
pubmed: 9817120